Literature DB >> 25603821

Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?

Pieter M M De Kesel1, Willy E Lambert, Christophe P Stove.   

Abstract

BACKGROUND AND
OBJECTIVE: Although metabolite-to-parent drug concentration ratios in hair have been suggested as a possible tool to study the metabolism of drugs in a non-invasive way, no studies are available that evaluated this in a systematic way. Cytochrome P450 (CYP) 1A2 is a drug-metabolizing enzyme characterized by large inter-individual differences in its activity. The standard approach for CYP1A2 phenotyping is to determine the paraxanthine/caffeine ratio in plasma at a fixed timepoint after intake of a dose of the CYP1A2 substrate caffeine. The aim of this study was to evaluate whether paraxanthine/caffeine ratios measured in hair samples reflect the plasma-based CYP1A2 phenotype.
METHODS: Caffeine and paraxanthine concentrations were measured in proximal 3 cm segments of hair samples from 60 healthy volunteers and resulting paraxanthine/caffeine ratios were correlated with CYP1A2 phenotyping indices in plasma.
RESULTS: Paraxanthine/caffeine ratios in hair ranged from 0.12 to 0.93 (median 0.41); corresponding ratios in plasma ranged from 0.09 to 0.95 (median 0.40). A statistically significant correlation was found between ratios in hair and plasma (r = 0.41, p = 0.0011). However, large deviations between ratios in both matrices were found in individual cases. Although the influence of several factors on paraxanthine/caffeine ratios and hair-plasma deviations was investigated, no evident factors explaining the observed variability could be identified.
CONCLUSION: The variability between hair and plasma ratios complicates the interpretation of hair paraxanthine/caffeine ratios on an individual basis and, therefore, compromises their practical usefulness as alternative CYP1A2 phenotyping matrix.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25603821     DOI: 10.1007/s40262-015-0237-7

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  33 in total

1.  Guidelines for European workplace drug and alcohol testing in hair.

Authors:  Ronald Agius; Pascal Kintz
Journal:  Drug Test Anal       Date:  2010-08       Impact factor: 3.345

Review 2.  State of the art in hair analysis for detection of drug and alcohol abuse.

Authors:  Fritz Pragst; Marie A Balikova
Journal:  Clin Chim Acta       Date:  2006-03-06       Impact factor: 3.786

3.  Hair nicotine:cotinine metabolic ratio in pregnant women: a new method to study metabolism in late pregnancy.

Authors:  Gideon Koren; Phillip Blanchette; Angelika Lubetzky; Michael Kramer
Journal:  Ther Drug Monit       Date:  2008-04       Impact factor: 3.681

4.  CYP1A2 phenotyping in dried blood spots and microvolumes of whole blood and plasma.

Authors:  Pieter M M De Kesel; Willy E Lambert; Christophe P Stove
Journal:  Bioanalysis       Date:  2014       Impact factor: 2.681

Review 5.  Mechanisms of drug incorporation into hair.

Authors:  G L Henderson
Journal:  Forensic Sci Int       Date:  1993-12       Impact factor: 2.395

6.  Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics.

Authors:  Vidya Perera; Annette S Gross; Hongmei Xu; Andrew J McLachlan
Journal:  J Pharm Pharmacol       Date:  2011-07-06       Impact factor: 3.765

Review 7.  Measurement of CYP1A2 activity: a focus on caffeine as a probe.

Authors:  Vidya Perera; Annette S Gross; Andrew J McLachlan
Journal:  Curr Drug Metab       Date:  2012-06-01       Impact factor: 3.731

8.  The role of variations in growth rate and sample collection on interpreting results of segmental analyses of hair.

Authors:  Marc A LeBeau; Madeline A Montgomery; Jason D Brewer
Journal:  Forensic Sci Int       Date:  2011-03-06       Impact factor: 2.395

9.  Correlation of cytochrome P450 (CYP) 1A2 activity using caffeine phenotyping and olanzapine disposition in healthy volunteers.

Authors:  Kara Lee Shirley; Yuen Y Hon; Scott R Penzak; Y W Francis Lam; Vicky Spratlin; Michael W Jann
Journal:  Neuropsychopharmacology       Date:  2003-03-19       Impact factor: 7.853

Review 10.  Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

Authors:  Ulrich M Zanger; Matthias Schwab
Journal:  Pharmacol Ther       Date:  2013-01-16       Impact factor: 12.310

View more
  2 in total

Review 1.  Alternative Sampling Strategies for Cytochrome P450 Phenotyping.

Authors:  Pieter M M De Kesel; Willy E Lambert; Christophe P Stove
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

2.  Determination of Urinary Caffeine Metabolites as Biomarkers for Drug Metabolic Enzyme Activities.

Authors:  Hyeong Jun Kim; Min Sun Choi; Shaheed Ur Rehman; Young Seok Ji; Jun Sang Yu; Katsunori Nakamura; Hye Hyun Yoo
Journal:  Nutrients       Date:  2019-08-19       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.